Key result
Streptokinase resolves catheter-induced subclavian vein thrombosis in a patient unresponsive to heparin.
Why the study?
Does streptokinase therapy improve outcomes in a patient with catheter-induced subclavian vein thrombosis refractory to heparin?
Case Report (n=1)
Does streptokinase therapy improve outcomes in a patient with catheter-induced subclavian vein thrombosis refractory to heparin?
Streptokinase may be an effective treatment for catheter-induced subclavian vein thrombosis when heparin fails.
Answers are grounded in this paper and cite their sources.
Streptokinase may resolve heparin-refractory subclavian thrombosis; single case leaves open efficacy, safety, and need for trials.
• Symptomatic subclavian vein thrombosis developed in a patient receiving long-term parenteral nutrition. Serial phlebograms showed progression of venous thrombosis, despite therapy with heparin. Fibrinolytic therapy with streptokinase, monitored in the laboratory by the euglobulin clot lysis time, was strikingly successful and may be the treatment of choice for this condition if certain contraindications are absent. (Arch Intern Med140:1370-1371, 1980)
No takes yet. Share an insight, caveat, or question.
M. Rubenstein (1980) conducted a case report in Catheter-Induced Subclavian Vein Thrombosis (n=1). Streptokinase vs. Heparin was evaluated on Treatment success. Fibrinolytic therapy with streptokinase was strikingly successful in treating catheter-induced subclavian vein thrombosis in a patient unresponsive to heparin.
Synapse has enriched 10 related papers. Consider them for comparative context: